Vericel Corp VCEL Stock Price & News

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion. NA2.63BNP Paribas Asset Management USA, Inc.2.31Shareholder percentage totals can add to more than 100% because some holders are included in the free float. By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Upgrade to MarketBeat All Access to add more stocks to your watchlist.

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. Morningstar Quantitative ratings for equities are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. 6 employees have rated Vericel Chief Executive Officer Nick Colangelo on Glassdoor.com.

How we use your personal data

A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.

• Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns.
• Do the numbers hold clues to what lies ahead for the stock…
• Intraday data delayed at least 15 minutes or per exchange requirements.
• 52 week low is the lowest price of a stock in the past 52 weeks, or one year.
• Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases.

Real-https://1investing.in/ last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Real-time analyst ratings, insider transactions, earnings data, and more.

NASDAQ: VCEL

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel is a leader in advanced therapies for sports medicine and severe burn care. The Company manufactures and markets two cell therapy products and one specialty biologic product in the United States. MACI® is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. 4 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Vericel in the last twelve months.

Vericel Insider Activity

CAMBRIDGE, Mass.—-Kytopen, an MIT-spin out and biotechnology company leading advancements in novel high-throughput cellular and genome engineering platforms, today announced the app… There may be delays, omissions, or inaccuracies in the Information. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank.

That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Vericel Corp.’s stock rocketed 92% in very active premarket trade Thursday, after the biotechnology company announced positive trial results for its heart failure treatment.

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases.

• This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
• This suggests a possible upside of 13.5% from the stock’s current price.
• The company issued revenue guidance of $180.00 million-$188.00 million, compared to the consensus revenue estimate of $192.58 million.
• According to 4 analysts, the average rating for VCEL stock is “Buy.” The 12-month stock price forecast is $32.75, which is an increase of 3.94% from the latest price.

In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Vericel’s stock was trading at $26.34 at the beginning of the year. Since then, VCEL shares have increased by 18.7% and is now trading at $31.27. According to analysts’ consensus price target of $35.50, Vericel has a forecasted upside of 12.7% from its current price of $31.51. Represents the company’s profit divided by the outstanding shares of its common stock.

Vericel to Present at the Ladenburg Thalmann Healthcare Conference

Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an “uptick” in price and the value of trades made on a “downtick” in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.

Nick Colangelo has an approval rating of 49% among the company’s employees. This puts Nick Colangelo in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Special Replay for The A.I. Predictive Power EventIf you missed The A.I. Predictive Power Event… don’t worry, for a limited time, we’ve made a replay available to the public. If you’re at or near retirement age, you don’t want to miss this… An-E’s predictions could help you make up any money you may have lost during the past 18 months and then some.

This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies. The company’s average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings. A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. Vericel Corporation saw its shares surge in the last session with trading volume being higher than average.

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. 52 week high is the highest price of a stock in the past 52 weeks, or one year. We’d like to share more about how we work and what drives our day-to-day business.

To see all exchange delays and terms of use please see Barchart’s disclaimer. One how to value a stock a traders guide to stock of VCEL stock can currently be purchased for approximately $31.27. Sign-up to receive the latest news and ratings for Vericel and its competitors with MarketBeat’s FREE daily newsletter. The P/E ratio of Vericel is -87.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes.

Vericel Corporation delivered earnings and revenue surprises of -16.67% and 3.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock… Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.Percent of FloatTotal short positions relative to the number of shares available to trade. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. The technique has proven to be very useful for finding positive surprises.

Shares of Vericel Corp. soared 65% in active premarket trade Wednesday, after the company said its treatment for cartilage defects of the knee was approved by the Food and Drug Administration. Vericel issued an update on its FY 2023 earnings guidance on Thursday, February, 23rd. The company issued revenue guidance of $180.00 million-$188.00 million, compared to the consensus revenue estimate of $192.58 million. The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023. In the past three months, Vericel insiders have not sold or bought any company stock. Vericel has a short interest ratio (“days to cover”) of 16.9, which indicates bearish sentiment.

During the event, we even reveal An-E’s predictions of the stock prices of TSLA, NVDA, and AAPL for FREE. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. As an investor, you want to buy stocks with the highest probability of success.

Short interest in Vericel has recently decreased by 2.29%, indicating that investor sentiment is improving. Measures how much net income or profit is generated as a percentage of revenue.

Since 1988 it has more than doubled the S&P 500 with an average gain of +24.27% per year. These returns cover a period from January 1, 1988 through April 3, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.